Eagle Pharmaceuticals, Inc.

GOLDMAN SACHS GROUP INC EGRX

Report date

9/30/2024

Quarter

2024 Q3

Filed

11/14/2024

Shares

31,495

Value ($000)

117

Weight

0.0%

2019 Q4 - 2024 Q3 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q3	11/14/2024	117	0.0%	31,495	9/30/2024
2024 Q2	8/13/2024	443	0.0%	79,093	6/30/2024
2024 Q1	5/15/2024	932	0.0%	177,807	3/31/2024
2023 Q4	5/14/2024	1,014	0.0%	193,824	12/31/2023
2023 Q3	5/15/2024	2,543	0.0%	161,253	9/30/2023
2023 Q2	5/14/2024	4,184	0.0%	215,230	6/30/2023
2023 Q1	5/14/2024	4,810	0.0%	169,546	3/31/2023
2022 Q4	5/14/2024	4,148	0.0%	141,894	12/31/2022
2022 Q3	5/14/2024	2,898	0.0%	109,677	9/30/2022
2022 Q2	5/14/2024	7,357	0.0%	165,582	6/30/2022
2022 Q1	5/16/2022	8,825	0.0%	178,306	3/31/2022
2021 Q4	2/17/2022	5,493	0.0%	107,868	12/31/2021
2021 Q3	1/20/2022	5,972	0.0%	107,076	9/30/2021
2021 Q2	8/13/2021	8,464	0.0%	197,762	6/30/2021
2021 Q1	5/17/2021	5,728	0.0%	137,222	3/31/2021
2020 Q4	2/12/2021	6,900	0.0%	148,169	12/31/2020
2020 Q3	11/13/2020	7,088	0.0%	166,866	9/30/2020
2020 Q2	8/12/2020	5,822	0.0%	121,343	6/30/2020
2020 Q1	5/15/2020	15,055	0.0%	327,293	3/31/2020
2019 Q4	2/14/2020	8,302	0.0%	138,173	12/31/2019